DS
Deepak Sharma
About Deepak Sharma
Data last updated:
Deepak Sharma is an Additional Director at Glucolabs Healthcare Private Limited (since 2022) and Managing Director at Divilabs Pharmaceuticals Private Limited (since 2021). The companies operate in Pharma. The largest current company by reported revenue is Glucolabs Healthcare Private Limited at ₹80.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 23 May 2022 | 2021 | ₹80.3 Lakh (FY 2025) | Active | |
| Managing Director | 03 Aug 2021 | 2021 | Active |
Board colleagues of Deepak Sharma
| Name | DIN | Company | Designation |
|---|---|---|---|
| Babita Saxena | 09052347 | Glucolabs Healthcare Private Limited | Director |
| Orikolodatte Perinchery Ravindran Nair | 09615358 | Glucolabs Healthcare Private Limited | Additional Director |
| Mayank Thakkar | 09265908 | Divilabs Pharmaceuticals Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deepak Sharma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepak Sharma
Deepak Sharma currently holds 2 directorships: Glucolabs Healthcare Private Limited (Additional Director, since 23 May 2022, revenue ₹80.3 Lakh (FY 2025)); Divilabs Pharmaceuticals Private Limited (Managing Director, since 03 Aug 2021).
Deepak Sharma was first appointed on 03 Aug 2021 as Managing Director at Divilabs Pharmaceuticals Private Limited. The most recent appointment on record is 23 May 2022 at Glucolabs Healthcare Private Limited.
The current boards of Deepak Sharma's companies include Babita Saxena (Glucolabs Healthcare Private Limited), Orikolodatte Perinchery Ravindran Nair (Glucolabs Healthcare Private Limited), Mayank Thakkar (Divilabs Pharmaceuticals Private Limited).